akin to 3'-azido-2',3'-dideoxythymidine ( azt ) , the sole anti-hiv compound that has so far been licensed for clinical use in the treatment of aids , all other ddn analogues are postulated to interact as competitive inhibitors ( with respect to the natural substrates ) and/or chain terminators of the hiv reverse transcriptase .
C0043474
azt
C0001175
aids